RGRX
Regenerx Biopharmaceuticals

213
Loading...
Loading...
RegeneRx Biopharmaceuticals, Inc. engages in the development of a novel therapeutic peptide, Thymosin beta 4 for tissue and organ protection, repair, and regeneration. Its product pipeline includes RGN-259, RGN-352, and RGN-137. The company was founded by Allan L. Goldstein on May 13, 1982 and is headquartered in Rockville, MD.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Regenerx Biopharmaceuticals?
What is the 52-week high for Regenerx Biopharmaceuticals?
What is the 52-week low for Regenerx Biopharmaceuticals?
What is Regenerx Biopharmaceuticals stock price today?
What was Regenerx Biopharmaceuticals stock price yesterday?
What is the 50-day moving average of Regenerx Biopharmaceuticals?

Latest RGRX News

View
No RGRX news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.